Aldehydes in cigarette smoke react with the lipid peroxidation product malonaldehyde to form fluorescent protein adducts on lysines

Chemical Research in Toxicology

Volumn 18, Issue 5, 2005, Pages 817-824

  Freeman, Thomas L ^a   Haver, Alvin ^b   Duryee, Michael J ^a   Tuma, Dean J ^a,b   Klassen, Lynell W ^a,b   Hamel, Frederick G ^b   White, Ronda L ^a   Rennard, Stephen I ^a   Thiele, Geoffrey M ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDROPYRIDINE 3,5 DICARBALDEHYDE; 4 BENZYL 1,4 DIHYDROPYRIDINE 3,5 DICARBALDEHYDE; 4 METHYL 1,4 DIHYDROPYRIDINE 3,5 DICARBALDEHYDE; 4 METHYL 1,4 DIHYDROPYRIDINE 3,5 DICARBALDEHYDE DERIVATIVE; 4 PROPYL 1,4 DIHYDROPYRIDINE 3,5 DICARBALDEHYDE; ALDEHYDE; ALPHA CYANO 4 HYDROXYCINNAMIC ACID; CALCITONIN GENE RELATED PEPTIDE; CIGARETTE SMOKE; FLUORESCENT DYE; LYSINE; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; DERIVATIZATION; ENVIRONMENTAL EXPOSURE; FOAM CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID PEROXIDATION; MACROPHAGE ACTIVATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDIATOR RELEASE; PROTEIN MODIFICATION;

ALDEHYDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIHYDROPYRIDINES; FLUORESCENCE; LIPID PEROXIDATION; LYSINE; MALONDIALDEHYDE; PROTEINS; SMOKING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS; TOBACCO; TOBACCO SMOKE POLLUTION;

EID: 18944363083     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx0500676     Document Type: Article

References (75)

1. Surgeon General (2004) The Health Consequences of Smoking: A Report of the Surgeon General, U.S. Department of Health & Human Services, Washington, D.C.; http.//www.surgeongeneral.gov/library/smokingconsequences/.
2. Rennard, S. I., and Daughton, D. M. (1998) Cigarette Smoking and Disease, McGraw-Hill, New York.
3. Higgins, M. (1984) Epidemiology of COPD. State of the art. Chest 85, 3S-8S.
4. Holbrook, J. H., Grundy, S. M., Hennekens, C. H., Kannel, W. B., and Strong, J. P. (1984) Cigarette smoking and cardiovascular diseases. A statement for health professionals by a task force appointed by the steering committee of the American Heart Association. Circulation 70, 1114A-1117A.
5. Janoff, A. (1986) Investigations into the biochemical mechanisms of pulmonary emphysema: Effects of cigarette smoke on enzymes and anti-enzymes in the lung. Respiration 50 (Suppl. 1), 13-25.
6. Janoff, A., Pryor, W. A., and Bengali, Z. H. (1987) NHLBI workshop summary. Effects of tobacco smoke components on cellular and biochemical processes in the lung. Am. Rev. Respir. Dis. 136, 1058-1064.
7. Jaimes, E. A., DeMaster, E. G., Tian, R. X., and Raij, L. (2004) Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler. Thromb. Vasc. Biol. 24, 1031-1036.
8. Kirkham, P. A., Spooner, G., Ffoulkes-Jones, C., and Calvez, R. (2003) Cigarette smoke triggers macrophage adhesion and activation: Role of lipid peroxidation products and scavenger receptor. Free Radical Biol. Med. 35, 697-710.
9. Lee, S. D., Lee, D. S., Chun, Y. G., Shim, T. S., Lim, C. M., Koh, Y., Kim, W. S., Kim, D. S., and Kim, W. D. (2001) Cigarette smoke extract induces endothelin-1 via protein kinase C in pulmonary artery endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 281, L403-L411.
10. Nordskog, B. K., Blixt, A. D., Morgan, W. T., Fields, W. R., and Hellmann, G. M. (2003) Matrix-degrading and pro-inflammatory changes in human vascular endothelial cells exposed to cigarette smoke condensate. Cardiovasc. Toxicol. 3, 101-117.
11. Ofulue, A. F., and Ko, M. (1999) Effects of depletion of neutrophils or macrophages on development of cigarette smoke-induced emphysema. Am. J. Physiol. 277, L97-L105.
12. Papamichael, C. M., Aznaouridis, K. A., Stamatelopoulos, K. S., Karatzis, E. N., Protogerou, A. D., Papaioannou, T. G., Lekakis, J. P., and Mavrikakis, M. E. (2004) Endothelial dysfunction and type of cigarette smoked: the impact of 'light' versus regular cigarette smoking. Vasc. Med. 9, 103-105.
13. Sela, B. A. (2002) Cigarette smoking and endothelial damage. Isr. Med. Assoc. J. 4, 1077-1079.
14. Li, A. C., Binder, C. J., Gutierrez, A., Brown, K. K., Plotkin, C. R., Pattison, J. W., Valledor, A. F., Davis, R. A., Willson, T. M., Witztum, J. L., Palinski, W., and Glass, C. K. (2004) Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J. Clin. Invest. 114, 1564-1576.
15. Kruth, H. S., Jones, N. L., Huang, W., Zhao, B., Ishii, I., Chang, J., Combs, C. A., Malide, D., and Zhang, W. Y. (2005) Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low-density lipoprotein. J. Biol. Chem. 280, 2352-2360.
16. Kruth, H. S., Huang, W., Ishii, I., and Zhang, W. Y. (2002) Macrophage foam cell formation with native low-density lipoprotein. J. Biol. Chem. 277, 34573-34580.
17. Gonen, B., Cole, T., and Hahm, K. S. (1983) The interaction of carbamylated low-density lipoprotein with cultured cells. Studies with human fibroblasts, rat peritoneal macrophages and human monocyte-derived macrophages. Biochim. Biophys. Acta 754, 201-207.
18. Fogelman, A. M., Shechter, I., Seager, J., Hokom, M., Child, J. S., and Edwards, P. A. (1980) Malondialdehyde alteration of low-density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc. Natl. Acad. Sci. U.S.A. 77, 2214-2218.
19. Mahley, R. W., Innerarity, T. L., Weisgraber, K. B., and Oh, S. Y. (1979) Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins. J. Clin. Invest. 64, 743-750.
20. Brown, M. S., and Goldstein, J. L. (1983) Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52, 223-261.
21. Yamada, S., Kumazawa, S., Ishii, T., Nakayama, T., Itakura, K., Shibata, N., Kobayashi, M., Sakai, K., Osawa, T., and Uchida, K. (2001) Immunochemical detection of a lipofuscin-like fluorophore derived from malondialdehyde and lysine. J. Lipid Res. 42, 1187-1196.
22. Hill, G. E., Miller, J. A., Baxter, B. T., Klassen, L. W., Duryee, M. J., Tuma, D. J., and Thiele, G. M. (1998) Association of malondialdehyde- acetaldehyde (MAA) adducted proteins with atherosclerotic-induced vascular inflammatory injury. Atherosclerosis 141, 107-116.
23. Kikugawa, K., Ido, Y., and Mikami, A. (1984) Studies on peroxidized lipids. VI. Fluorescent products derived from the reaction of primary amines, malonaldehyde and monofunctional aldehydes. JAOCS 61, 1574-1581.
24. Petruzzelli, S., Hietanen, E., Bartsch, H., Camus, A. M., Mussi, A., Angeletti, C. A., Saracci, R., and Giuntini, C. (1990) Pulmonary lipid peroxidation in cigarette smokers and lung cancer patients. Chest 98, 930-935.
25. Kalra, J., Chaudhary, A. K., and Prasad, K. (1991) Increased production of oxygen free radicals in cigarette smokers. Int. J. Exp. Pathol. 72, 1-7.
26. Bridges, A. B., Scott, N. A., Parry, G. J., and Belch, J. J. (1993) Age, sex, cigarette smoking and indices of free radical activity in healthy humans. Eur. J. Med. 2, 205-208.
27. van Antwerpen, V. L., Theron, A. J., Richards, G. A., Steenkamp, K. J., van der Merwe, C. A., van der Walt, R., and Anderson, R. (1995) Vitamin E, pulmonary functions, and phagocyte-mediated oxidative stress in smokers and nonsmokers. Free Radical Biol. Med. 18, 935-941.
28. Kikugawa, K., Kosugi, H., and Asakura, T. (1984) Effect of malondialdehyde, a product of lipid peroxidation, on the function and stability of hemoglobin. Arch. Biochem. Biophys. 229, 7-14.
29. Agarwal, R., and Chase, S. D. (2002) Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples. J. Chromatogr., B: Biomed. Sci. Appl. 775, 121-126.
30. Fukunaga, K., Takama, K., and Suzuki, T. (1995) High-performance liquid chromatographic determination of plasma malondialdehyde level without a solvent extraction procedure. Anal. Biochem. 230, 20-23.
31. Kreindler, J. L., Jackson, A., Kemp, P., Bridges, R. J., and Danahay, H. (2004) Inhibition of chloride secretion in human bronchial epithelial cells by cigarette smoke extract. Am. J. Physiol. Lung Cell Mol. Physiol. (in press).
32. Martey, C. A., Pollock, S. J., Turner, C. K., O'Reilly, K. M., Baglole, C. J., Phipps, R. P., and Sime, P. J. (2004) Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer. Am. J. Physiol. Lung Cell Mol. Physiol. 287, L981-L991.
33. Korchazhkina, O., Exley, C., and Andrew Spencer, S. (2003) Measurement by reversed-phase high-performance liquid chromatography of malondialdehyde in normal human urine following derivatisation with 2,4-dinitrophenylhydrazine. J. Chromatogr., B: Biomed. Sci. Appl. 794, 353-362.
34. Cordis, G. A., Bagchi, D., Maulik, N., and Das, D. K. (1994) High-performance liquid chromatographic method for the simultaneous detection of malonaldehyde, acetaldehyde, formaldehyde, acetone and propionaldehyde to monitor the oxidative stress in heart. J. Chromatogr., A 661, 181-191.
35. Bagchi, D., Bagchi, M., Hassoun, E., Moser, J., and Stohs, S. J. (1993) Effects of carbon tetrachloride, menadione, and paraquat on the urinary excretion of malondialdehyde, formaldehyde, acetaldehyde, and acetone in rats. J. Biochem. Toxicol. 8, 101-106.
36. Moser, J., Bagchi, D., Akubue, P. I., and Stohs, S. J. (1993) Excretion of malondialdehyde, formaldehyde, acetaldehyde and acetone in the urine of rats following acute and chronic administration of ethanol. Alcohol Alcohol. 28, 287-295.
37. National Institute for Occupational Safety and Health (1991) Current Intelligence Bulletin 54: Environmental Tobacco Smoke in the Workplace-Lung Cancer and Other Health Effects, pp 1-16, National Institute for Occupational Safety and Health, Washington, DC.
38. Allwright, S., McLaughlin, J. P., Murphy, D., Pratt, I., Ryan, M. A. S., and Guihen, B. (2002) Report on the Health Effects of Environmental Tobacco Smoke (ETS) in the Workplace, Health and Safety Authority and Office of Tobacco Control, Dublin, Ireland.
39. Houlgate, P. R., Dhingra, K. S., Nash, S. J., and Evans, W. H. (1989) Determination of formaldehyde and acetaldehyde in mainstream cigarette smoke by high-performance liquid chromatography. Analyst 114, 355-360.
40. Seeman, J. I., Dixon, M., and Haussmann, H. J. (2002) Acetaldehyde in mainstream tobacco smoke: Formation and occurrence in smoke and bioavailability in the smoker. Chem. Res. Toxicol. 15, 1331-1350.
41. Smith, C. J., and Hansch, C. (2000) The relative toxicity of compounds in mainstream cigarette smoke condensate. Food Chem. Toxicol. 38, 637-646.
42. Tuma, D. J., and Casey, C. A. (2003). Dangerous byproducts of alcohol breakdown-Focus on adducts. Alcohol Res. Health 27, 285-290.
43. Tuma, D. J. (2002) Role of malondialdehyde-acetaldehyde adducts in liver injury. Free Radical Biol. Med. 32, 303-308.
44. Thiele, G. M., Worrall, S., Tuma, D. J., Klassen, L. W., Wyatt, T. A., and Nagata, N. (2001) The chemistry and biological effects of malondialdehyde-acetaldehyde adducts. Alcohol Clin. Exp. Res. 25, 218S-224S.
45. Tuma, D. J., Thiele, G. M., Xu, D., Klassen, L. W., and Sorrell, M. F. (1996) Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration. Hepatology 23, 872-880.
46. Willis, M. S., Klassen, L. W., Tuma, D. J., and Thiele, G. M. (2002) Malondialdehyde-acetaldehyde-haptenated protein induces cell death by induction of necrosis and apoptosis in immune cells. Int. Immunopharmacol. 2, 519-535.
47. Benzie, I. F. (1996) Lipid peroxidation: a review of causes, consequences, measurement and dietary influences. Int. J. Food Sci. Nutr. 47, 233-261.
48. Delibas, N., Ozcankaya, R., Altuntas, I., and Sutcu, R. (2003) Effect of cigarette smoke on lipid peroxidation, antioxidant enzymes and NMDA receptor subunits 2A and 2B concentration in rat hippocampus. Cell Biochem. Funct. 21, 69-73.
49. Sandhir, R., Subramanian, S., and Koul, A. (2003) Long-term smoking and ethanol exposure accentuates oxidative stress in hearts of mice. Cardiovasc. Toxicol. 3, 135-140.
50. van der Vaart, H., Postma, D. S., Timens, W., and ten Hacken, N. H. (2004) Acute effects of cigarette smoke on inflammation and oxidative stress: A review. Thorax 59, 713-721.
51. Karats, D., Ben-Naim, M., Dabach, Y., Hollander, G., Stein, O., and Stein, Y. (1989) Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. Atherosclerosis 79, 245-252.
52. Nielsen, F., Mikkelsen, B. B., Nielsen, J. B., Andersen, H. R., and Grandjean, P. (1997) Plasma malondialdehyde as biomarker for oxidative stress: Reference interval and effects of life-style factors. Clin. Chem. 43, 1209-1214.
53. Panda, K., Chattopadhyay, R., Chattopadhyay, D. J., and Chatterjee, I. B. (2000) Vitamin C prevents cigarette smoke-induced oxidative damage in vivo. Free Radical Biol. Med. 29, 115-124.
54. Helen, A., and Vijayammal, P. L. (1997) Vitamin C supplementation on hepatic oxidative stress induced by cigarette smoke. J. Appl. Toxicol. 17, 289-295.
55. Helen, A., and Vijayammal, P. L. (1997) Effect of vitamin A supplementation on cigarette smoke-induced lipid peroxidation. Vet. Hum. Toxicol. 39, 18-21.
56. Church, D. F., and Pryor, W. A. (1985) Free-radical chemistry of cigarette smoke and its toxicological implications. Environ. Health Perspect. 64, 111-126.
57. MacNee, W., Wiggs, B., Belzberg, A. S., and Hogg, J. C. (1989) The effect of cigarette smoking on neutrophil kinetics in human lungs. N. Engl. J. Med. 321, 924-928.
58. Eiserich, J. P., van der Vliet, A., Handelman, G. J., Halliwell, B., and Cross, C. E. (1995) Dietary antioxidants and cigarette smoke-induced biomolecular damage: A complex interaction. Am. J. Clin. Nutr. 62, 1490S-1500S.
59. Rahman, I., and MacNee, W. (1999) Lung glutathione and oxidative stress: Implications in cigarette smoke-induced airway disease. Am. J. Physiol. 277, L1067-L1088.
60. Squadrito, G. L., Cueto, R., Dellinger, B., and Pryor, W. A. (2001) Quinoid redox cycling as a mechanism for sustained free radical generation by inhaled airborne particulate matter. Free Radical Biol. Med. 31, 1132-1138.
61. Stocker, R., and Keaney, J. F., Jr. (2004) Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84, 1381-1478.
62. Scanu, A. M. (2003) Lipoprotein(a) and the atherothrombotic process: Mechanistic insights and clinical implications. Curr. Atheroscler. Rep. 5, 106-113.
63. Gaut, J. P., and Heinecke, J. W. (2001) Mechanisms for oxidizing low-density lipoprotein. Insights from patterns of oxidation products in the artery wall and from mouse models of atherosclerosis. Trends Cardiovasc. Med. 11, 103-112.
64. Santanam, N., Sanchez, R., Hendler, S., and Parthasarathy, S. (1997) Aqueous extracts of cigarette smoke promote the oxidation of low-density lipoprotein by peroxidases. FEBS Lett. 414, 549-551.
65. Vruwink, K. G., Gershwin, M. E., Sachet, P., Halpern, G., and Davis, P. A. (1996) Modification of human LDL by in vitro incubation with cigarette smoke or copper ions: Implications for allergies, asthma and atherosclerosis. J. Invest. Allergol. Clin. Immunol. 6, 294-300.
66. Kagota, S., Yamaguchi, Y., Shinozuka, K., Kwon, Y. M., and Kunitomo, M. (1996) Cigarette smoke-modified low-density lipoprotein impairs endothelium-dependent relaxation in isolated rabbit arteries. Gen. Pharmacol. 27, 477-481.
67. Yokode, M., Nagano, Y., Arai, H., Ueyama, K., Ueda, Y., and Kita, T. (1995) Cigarette smoke and lipoprotein modification. A possible interpretation for development of atherosclerosis. Ann. N. Y. Acad. Sci. 748, 294-300.
68. Mahfouz, M. M., Hulea, S. A., and Kummerow, F. A. (1995) Cigarette smoke increases cholesterol oxidation and lipid peroxidation of human low-density lipoprotein and decreases its binding to the hepatic receptor in vitro. J. Environ. Pathol. Toxicol. Oncol. 14, 181-192.
69. Duryee, M. J., Willis, M. S., Freeman, T. L., Kuszynski, C. A., Tuma, D. J., Klassen, L. W., and Thiele, G. M. (2004) Mechanisms of alcohol liver damage: aldehydes, scavenger receptors, and autoimmunity. Front Biosci. 9, 3145-3155.
70. Thiele, G. M., Duryee, M. J., Willis, M. S., Sorrell, M. F., Freeman, T. L., Tuma, D. J., and Klassen, L. W. (2004) Malondialdehyde-acetaldehyde (MAA) modified proteins induce pro-inflammatory and pro-fibrotic responses by liver endothelial cells. Comp. Hepatol. 3 (Suppl. 1), S25.
71. Thiele, G. M., Freeman, T. L., and Klassen, L. W. (2004) Immunologic mechanisms of alcoholic liver injury. Semin. Liver Dis. 24, 273-287.
72. Willis, M. S., Thiele, G. M., Tuma, D. J., and Klassen, L. W. (2003) T cell proliferative responses to malondialdehyde-acetaldehyde haptenated protein are scavenger receptor mediated. Int. Immunopharmacol. 3, 1381-1399.
73. Rolla, R., Vay, D., Mottaran, E., Parodi, M., Traverso, N., Arico, S., Sartori, M., Bellomo, G., Klassen, L. W., Thiele, G. M., Tuma, D. J., and Albano, E. (2000) Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease. Hepatology 31, 878-884.
74. Thiele, G. M., Tuma, D. J., Willis, M. S., Miller, J. A., McDonald, T. L., Sorrell, M. F., and Klassen, L. W. (1998) Soluble proteins modified with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant. Alcohol Clin. Exp. Res. 22, 1731-1739.
75. Klassen, L. W., and Thiele, G. M. (1998) Immune reactivity to proteins biotransformed by alcohol metabolites. Alcohol Clin. Exp. Res. 22, 204S-207S.